- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Hercules Today
By the People, for the People
Mangrove Partners IM LLC Invests $35.57 Million in Bio-Rad Laboratories
The investment firm acquired a new stake in the medical research company's stock
Mar. 14, 2026 at 10:56am
Got story updates? Submit your updates here. ›
Mangrove Partners IM LLC acquired a new stake of 126,853 shares in Bio-Rad Laboratories, Inc. (NYSE:BIO) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The stake is valued at approximately $35,568,000, making Bio-Rad Laboratories the 14th largest position in Mangrove Partners IM LLC's investment portfolio.
Why it matters
This investment highlights the continued investor interest in Bio-Rad Laboratories, a leading provider of life science research and clinical diagnostic products. The company's diverse product offerings and strong market position have made it an attractive target for institutional investors looking to gain exposure to the growing medical research industry.
The details
Mangrove Partners IM LLC acquired the new stake in Bio-Rad Laboratories during the third quarter of the year. The 126,853 shares purchased represent about 0.47% of the company's outstanding stock. Bio-Rad Laboratories is known for its instruments, reagents and consumables used in protein analysis, cell biology, gene expression and other molecular biology applications, as well as its clinical diagnostics products.
- Mangrove Partners IM LLC acquired the new stake in Bio-Rad Laboratories during the third quarter of 2026.
The players
Mangrove Partners IM LLC
An investment management firm that acquired a new stake in Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc.
A global provider of life science research and clinical diagnostic products, including instruments, reagents and consumables used in various molecular biology applications.
The takeaway
This investment by Mangrove Partners IM LLC underscores the continued appeal of Bio-Rad Laboratories as a leading player in the growing medical research industry. The company's diverse product portfolio and strong market position have made it an attractive target for institutional investors seeking exposure to this dynamic sector.
